New research was presented at the 2021 Alzheimer’s Association International Conference (AAIC) showing that cleaner air could reduce an individual’s risk of developing dementia. This follows research indicating that there could be a link between air pollution and the risk of developing dementia, specifically Alzheimer’s disease. One study was funded by the National Institutes of … Read more
A new blood test known as Signatera has shown incredible ability to detect cancer relapses long before traditional scans, making it a game changer for patients.
The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact on the treatment and decision paths of patients with both high-risk and early-stage breast cancer. The study also showed that Lynparza reduces the chances that patients with the BRCA gene … Read more
New research finds a connection between ancestry and Alzheimer’s disease, which can help improve early detection and management.
Read about Alex Dembitzer’s connection to Ezer Mizion, an organization in Israel that has impacted the lives of thousands in need.
Findings from a PARP inhibitor study presented at the Society of Gynecologic Oncology’s virtual medical conference have shown promising results.
What are BRCA1 and BRCA2 mutated genes? Who is at risk? What does prevention/counseling look like for those with the mutation?
The Tzippora Fried Alzheimer’s Center in Israel has continued to operate in full swing over the past year, despite the challenges of the coronavirus.
The Tzippora Fried Alzheimer’s Center in Israel has continued to operate in full swing over the past year, despite the challenges of the coronavirus.
Researchers at Tel Aviv University have successfully treated cancer in mice using gene-editing CRISPR technology.